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Abstract
While intermittent hypoxic training (IHT) has been reported to evoke cellular responses via hypoxia inducible factors (HIFs)
but without substantial performance benefits in endurance athletes, we hypothesized that repeated sprint training in
hypoxia could enhance repeated sprint ability (RSA) performed in normoxia via improved glycolysis and O2 utilization. 40
trained subjects completed 8 cycling repeated sprint sessions in hypoxia (RSH, 3000 m) or normoxia (RSN, 485 m). Before
(Pre-) and after (Post-) training, muscular levels of selected mRNAs were analyzed from resting muscle biopsies and RSA
tested until exhaustion (10-s sprint, work-to-rest ratio 1:2) with muscle perfusion assessed by near-infrared spectroscopy.
From Pre- to Post-, the average power output of all sprints in RSA was increased (p,0.01) to the same extent (6% vs 7%, NS)
in RSH and in RSN but the number of sprints to exhaustion was increased in RSH (9.464.8 vs. 13.066.2 sprints, p,0.01) but
not in RSN (9.364.2 vs. 8.963.5). mRNA concentrations of HIF-1a (+55%), carbonic anhydrase III (+35%) and
monocarboxylate transporter-4 (+20%) were augmented (p,0.05) whereas mitochondrial transcription factor A (240%),
peroxisome proliferator-activated receptor gamma coactivator 1a (223%) and monocarboxylate transporter-1 (236%) were
decreased (p,0.01) in RSH only. Besides, the changes in total hemoglobin variations (D[tHb]) during sprints throughout RSA
test increased to a greater extent (p,0.01) in RSH. Our findings show larger improvement in repeated sprint performance in
RSH than in RSN with significant molecular adaptations and larger blood perfusion variations in active muscles.
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Introduction
Hypoxic conditions can be characterized in working muscle
by a decreased oxygen tension (e.g. lower myoglobin oxygen
saturation and intramyocellular oxygen partial pressure) [1].
There are some evidences that exercising in hypoxia affects
muscular functions [2] and a large number of genes mediated
by hypoxia-inducible factors (HIFs) [3]. These transcription
factors have been demonstrated to control the expression of
over 70 targets in response to a reduction in oxygen
concentration. Intermittent hypoxic training (IHT) has been
reported to evoke cellular responses via HIF1-a [4,5] but
without demonstrating substantial performance benefits in
endurance athletes [6–8]. Actually, training intensity in hypoxia
per se modulates molecular adaptations at muscular level with
‘‘adaptations that compensate for the reduced availability of
oxygen during exercise’’ [9]. Then, any limitation in O2
availability (e.g. exercising in hypoxia) induces a compensatory
vasodilation shifting blood flow upward to keep constant O2
delivery to the muscle. This later mechanism is also influenced
by the exercise intensity [10]. For example, during supramax-
imal efforts, an increase in skeletal muscle blood flow allows
matching the augmented O2 demand tightly [11].
Indeed, repeated sprints (RS) consist in maximal intensity
exercise bouts with incomplete recoveries and could potentially
challenge these adaptive mechanisms if performed in hypoxia. RS
require huge energy amounts over short periods of time provided
primarily by anaerobic glycolysis [12] with a progressive rise in the
energy contribution of the aerobic metabolism [13]. One may
therefore speculate that HIF-mediated molecular adaptations
induced by repeated maximal efforts in hypoxia may challenge
the functional reserve in muscle oxygen diffusing capacity likely
utilized in hypoxia [14].
Besides, fast-twitch fibers (FT), preferentially recruited while
sprinting [15], may better adjust to a high energetic demand with
a greater fractional O2 extraction than their slow twitch counter-
parts [16] if oxygen tension falls in the muscle (e.g. in hypoxia).
Consequently it can be hypothesized that RS training in hypoxia
(RSH) could induce beneficial adaptations at the muscular level
with an improved blood perfusion level inducing an enhanced O2
utilization by FT.
Nonetheless, to our knowledge, these mechanisms and the
potential associated benefits for the ability to repeat sprints in
normoxia have never been investigated in a randomized blind
controlled study. The goal of our study was therefore to test
putative additional benefit on systemic repeated sprint ability
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performance of RS training in hypoxia vs. normoxia and to assess
blood perfusion and molecular responses at the muscular level.
Methods
Subjects
50 moderately trained male cyclists (age 3567 years, height
17965 cm, mass 7569 kg) volunteered in the study and provided
their written informed consent after the state Medical Ethics
Committee approved the protocol (Commission Cantonale
Valaisanne d’Ethique Me´dicale, CCVEM, Agreement 07/10,
Sion, Switzerland). Subjects were all non-smokers lowlanders.
None of the subjects were acclimatized or recently exposed to
altitude and were asked to avoid any exposure to an altitude of
more than 1500 m during the protocol.
Study Design
Experimental protocol consisted in two testing sessions before
(Pre-) and after (Post-) a four-week supervised specific training
period (8 training sessions). Subjects were randomly assigned to
one of the two treatment groups with repeated sprint training
either in normoxia (RSN, n= 20) or hypoxia (RSH, n= 20). A
control group (CON, n= 10) completed only Pre- and, after four
weeks without specific training, Post-. Subjects were not specifi-
cally accustomed with 10 s cycling sprints but they were familiar
with laboratory testing and longer high intensity cycling intervals.
Protocol was run in single-blind fashion, as subjects both in RSH
and RSN were told that all training sessions were held at altitude
(without any accurate information on the altitude level). When
asked, 95% of the subjects in RSH and 85% in RSN declared that
their training was performed in hypoxia. Analyzes of blood
samples and muscle biopsies were performed double-blinded.
Supervised Training Protocol
Volunteers completed eight specific cycling training sessions
with repeated sprints during four weeks starting the week after Pre-
and finishing the week before Post-. Two sessions per week were
completed in a hypoxic chamber (ATS Altitude, Sydney,
Australia) built in our laboratory at an altitude of 485 m (Sion,
Switzerland). The hypoxic chamber is a well-ventilated 30 cu. m
room (2.4 m65.0 m62.5 m) with transparent glass panels. The
system consists in a compressor storing air in pressurized tanks
with serial connection to air filters allowing oxygen reduction
(altitude simulation) in the air input flow to the chamber. For
RSH, inspired oxygen fraction (FiO2) was set to 14.6% to simulate
an altitude of 3000 m and controlled regularly with an electronic
device (GOX 100 oximeter, Greisinger, Regenstauf, Germany). In
order to blind subjects to altitude, the system was also run for RSN
with a normoxic airflow into the chamber. Air input flow (up to
1000 l/min) was sufficient for safe, comfortable and stable training
conditions. Temperature inside the chamber was maintained at
25u in average and three fans and crushed ice buckets were used to
cool subjects.
Training Sessions
Following 10 min warm-up at 120 W, all training sessions
consisted in 3 sets of 5610 s all-out repeated sprints with a 5 min
recovery period at 120 W between sprints and sets and ending
with 10 min recovery at 120 W (Fig. 1). Subjects were instructed
to perform all-out sprints trying to reach and maintain the highest
power output for every sprint. Each session lasted 36 min 30 s and
subjects spent ,40 min in the chamber for every training session
(320 min during the 4-weeks training period). Up to four subjects
trained simultaneously in the chamber using their own road
bicycle equipped with a power meter (Powertap Pro+ Wheel,
Cycleops, Madison, USA) mounted on a stationary trainer with
magnetic resistance (Powertap Supermagneto Pro, Cycleops,
Madison, USA). Power output and heart rate were recorded for
each training session. Electrolytes-carbohydrates sports drink
(Isotonic, Sponser, Wollerau, Switzerland) and water were pro-
vided to ensure appropriate hydration and carbohydrate intake
during training. After each session, subjects reported their rate of
perceived exertion (RPE, Borg Scale, 6–20) and ticked the level of
pain in the legs on a continuous visual analogic scale (VAS).
Training sessions were scheduled with at least one day of rest in
between for optimal recovery. Outside of the laboratory,
volunteers were asked to maintain their usual endurance training
avoiding any intense training and to fill a training diary.
Baseline (Pre-) and Final (Post-) Tests
During the 48 h prior to each testing session, subjects were
asked to refrain from any training or exhaustive activity. Due to
the extreme intensity of the tests, subjects were asked not to report
to the laboratory on an empty stomach. A standard breakfast
(cornflakes or muesli with milk, bread with jam and water) was
therefore advised. In all cases, subjects were asked to fill
a nutritional diary for three days before each test and reproduce
the last meals avoiding alcohol and caffeine intakes during the
24 h before each test. Tap water was provided ad libitum during the
tests. Pre- and Post- trials were performed in the exact same
sequence in normoxia in the well-ventilated laboratory at
a constant temperature of 24uC.
Blood Sampling and Muscle Biopsies
Upon arrival in the morning, subjects were weighed and
a 2,5 ml blood sample was then taken from the antecubital vein for
immediate hematocrit and hemoglobin concentration ([Hb])
evaluation. Gold standard hematocrit measurement was done by
centrifugation of heparinized capillaries during 5 min at
13000 rpm (Haematokrit 210 Centrifuge, Hettich, Germany).
[Hb] was assessed with a photometry device (Hemocue 201,
A¨ngeholm, Sweden). Blood lactate concentration ([La]) was
measured from a capillary fingertip sample (Lactate Pro, Arkray,
Japan) at rest and immediately after each test.
Resting skeletal muscle microbiopsy samples were taken under
local anaesthesia (RapidocaineH, 1% plain) of the left leg from the
belly of the vastus lateralis muscle using percutaneous needle biopsy
technique (Pro-Mag, Medical Device Technologies Inc., Gains-
ville, USA) [17]. Three individual muscle samples (between 60 and
90 mg of muscle) were taken within less than 1 min from one
single incision. The muscle samples were washed in saline solution
then immediately frozen in liquid nitrogen for RNA and protein
extraction. For practical reasons muscle biopsies were taken in 5
subjects only in CON.
RNA Extraction and Real Time Quantitative PCR
RNA from skeletal muscle (approximately 25 mg of muscle) was
extracted using a commercially available preparation, peqGOLD
Tri-Fast (Peqlab, Germany). Five micrograms of RNA were
reverse transcribed to cDNA using Random Hexamer primers
(Promega AG, Switzerland) and AffinityScript Multiple Temper-
ature Reverse Transcriptase (Agilent Technologies Inc, Santa
Clara, CA, USA), while quantitative PCR was performed using an
MX3000p thermal cycler system and Brilliant SYBER Green
QPCR Master Mix (Agilent Technologies). PCR primers
sequences are listed in Table 1 and PCR conditions were used
as published previously by our research group [17,18]. To control
for any variations due to efficiencies of the reverse transcription
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and PCR, acidic ribosomal phosphoprotein P0 (RPLP0 or 36B4)
was used as an internal control. All PCR runs were performed in
triplicate.
Enzyme Activities
20 mg of tissue were used to measure enzyme activities of
interest in RSH and RSN but not in CON. Lactate dehydrogenase
(LDH) activity was determined using a colorimetric method
developed by BioAssay system (QuantiChrom) according to
manufacturer’s instructions. The non-radioactive colorimetric
LDH assay is based on the reduction of the tetrazolium salt
MTT in a NADH-coupled enzymatic reaction to a reduced form
of MTT which exhibits an absorption maximum at 565 nm [19].
Measurement of citrate synthase (CS) activity was performed by
linking the release of Coenzyme-A to the colometric agent DTNB
5,5-dithiobis-2-nitrobenzoate. Changes in absorbance were fol-
lowed at 412 nm [20].
Exercise Performance Tests and Measurements
An electronically braked cycling ergometer (Lode Excalibur
Sport, Groninge, The Netherlands) equipped with clip-on pedals
was used for all performance tests. Seating and handlebar positions
were adjusted individually for all subjects and reproduced for all
tests. For each performance test, maximal instantaneous power
output and pedaling frequency (PF) were recorded and average
power output calculated. All tests were performed against an
individual fixed torque of 0.8 Nm.kg-1 with the ergometer in
manufacturer’s ‘‘Wingate mode’’ unless otherwise specified. RPE
and leg pain were assessed as described above.
Near-infrared Spectroscopy Measurements
Muscle oxygenation was assessed using a near-infrared spec-
troscopy (NIRS) technique well described elsewhere [21]. The
NIRS device (Oxymon Mk III, Artinis, Zetten, The Netherlands
intramuscular oxygenation) was used to measure changes in
muscle oxygenation by placing a double optode sensor on m. vastus
lateralis on the right leg, at mid thigh with an interoptode spacing of
40 mm. The probe was attached to the skin with double-sided tape
and firmly fastened with an opaque cotton elastic band wrapped
around subjects’ thigh. Position of the probe was marked during
Pre- with a permanent pen for accurate repositioning in the Post-
trial. A standard differential pathlength factor (DPF) of 4.0 was
used in lack of any clear standard value for human quadriceps
muscle during cycling sprints [22,23]. All signals were recorded
with a sampling frequency of 50 Hz. They were down sampled at
10 Hz using Matlab (Matlab Software, Nattick (MA) USA) routine
resample. Then a 10th-order low-pass zero-phase Butterworth
filter (cutoff frequency 0.1 Hz) was applied to the resampled
signals in order to remove possible artifacts and smooth the
pedaling-induced perturbations. Automatic detection of the
starting and end times of the successive sprints was obtained by
estimating the filtered desoxyhemoglobin signal upper and lower
envelopes using local minima and maxima in a sliding window of
length 400 samples (4 s). The starting and end times were obtained
as the times of contact between the envelopes and the signal. This
allowed the determination of maximum and minimum for each
signal during the successive sprint and recovery phases. Concen-
Figure 1. Description of a typical training session.
doi:10.1371/journal.pone.0056522.g001
Table 1. Quantitative PCR primer sequences.
Gene Sequence 5–3 Temperature
MCT-1 Sense CCA AGG CAG GGA AAG ATA AGT CT 60
Anti ATC TTT TTT CAC ACC AGA TTT TCC A
MCT-4 Sense GCA CCC ACA AGT TCT CCA GT 60
Anti CAA AAT CAG GGA GGA GGT GA
CA3 Sense GTC CTC TCC CTG GAC CCT AC 60
Anti TTG TCC AAT GCA TCA AGG AA
Tfam Sense CCA AAA AGA CCT CGT TCA GCT TA 60
Anti TGC GGT GAA TCA CCC TTA GC
Mb Sense GCA TGC CAC CAA GCA CAA G 60
Anti TGA TGC ATT CCG AGA TGA ACT C
PGC-1a Sense GGT CTC TCC TTG CAG CAC AAG 60
Anti CTG GGA TGA CCG AAG TGC TT
VEGF Sense CCT TGC TGC TCT ACC TCC AC 60
Anti ATC TGC ATG GTG ATG TTG GA
HIF-1a Sense TCC ATG TGA CCA TGA GGA AA 60
Anti CCA AGC AGG TCA TAG GTG GT
RPLP0 Sense GTG ATG TGC AGC TGA TCA AGA CT 60
Anti GAT GAC CAG CCC AAA GGA GA
MCT-1, monocarboxylate transporter 1; MCT-4, monocarboxylate transporter 4;
CA3, carbonic anhydrase III; Tfam, transcription factor A mitochondrial; Mb,
myoglobin; PGC-1a, peroxisome proliferator-activated receptor gamma,
coactivator 1 alpha; VEGF, vascular endothelial growth factor A; HIF-1, hypoxia
inducible factor 1, alpha subunit; RPLP0, ribosomal protein large P0.
doi:10.1371/journal.pone.0056522.t001
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trations for oxyhemoglobin ([O2Hb]), desoxyhemoglobin ([HHb])
and total hemoglobin/myoglobin ([tHb]) were determined.
Figure 2 illustrates the typical signals recorded by NIRS. Since
[HHb] values were proposed to be less sensitive than [O2Hb] to
blood flow variations [24] and changes in O2Hb signals might be
confounded by rapid blood volume changes during sprints [25]
only [HHb] and [tHb] were analyzed for relevant interpretations.
Differences between maximum and minimum concentrations were
defined as the amplitude of the variation for each sprint (D[tHb]
and D[HHb]). Thus, for example, at the beginning of each sprint
a minimum value for [HHb] is measured whereas [HHb] reaches
a maximum at the end of each sprint. Conversely, a maximum in
[tHb] is observed at the beginning of each sprint (i.e. end of each
recovery period) and [tHb] decreases to reach a minimum value at
the end of each sprint. The amplitudes of the first sprint were
standardized as 100%. Amplitudes during the following sprints
and the average value for all sprints throughout the RSA test (i.e.
D[HHb]av and D[tHb]av) were calculated. The same analysis was
performed during the successive recovery phases. In addition, the
D[tHb]/Power was calculated as the ratio between D[tHb] and
mean power for each sprint as an index of blood perfusion relative
to the intensity of each sprint.
Electromyography Acquisition and Analysis
Surface EMG of the vastus lateralis (VL) and biceps femoris (BF)
muscles on the right leg were recorded during the tests using
MP36 hardware (Biopac Systems Inc., Santa Barbara, CA) with
specific electrodes (EL-503, Biopac) with a diameter of 35 mm
pasted longitudinally on the distal part of the muscle belly with an
center-to-center distance of 25 mm. A ground electrode was
located on the patella. Prior to electrode placement, skin on the
surface of these muscles was carefully shaved, abraded and cleaned
(impedance ,5 kV). EMG cables running inside subjects’ cycling
tights prevented cables movement. The myoelectric signal was
collected at 2000 Hz, amplified and filtered (pass band 5–500 Hz,
gain = 1000). EMG parameters were then computed in a dedicated
software (AcqKnowledge 4.1.0, Biopac Systems Inc., Santa
Barbara, CA). During RS, each muscle activity was determined
by calculating the mean value of the root mean square (RMS) of
the signal for each sprint. Average values were then calculated for
the entire duration (10 s) of each sprint.
Repeated Sprint Ability Test
Approximately 20 min after the resting biopsy, subjects
performed a 5 min warm-up at 120 W at their preferred PF
followed by an isolated 10 s sprint, 4 min 50 s recovery at 120 W
and a second isolated 10 s sprint. 15 s after this second sprint,
subjects were asked to stop pedaling and rest keeping the right leg
motionless and straight during 5 min for NIRS baseline measure-
ment. Subjects then started pedaling for 45 s against a 20 W
resistance at a PF of approximately 85 rpm followed immediately
by the repeated sprint ability (RSA) test with a 1:2 work-to-rest
ratio (10 s all-out sprint and 20 s rest). Immediately after each
sprint, the ergometer switched automatically to a resistance of
20 W during the 20 s active recovery phase. Subjects were given
very strong verbal encouragement and performed as many sprints
as possible until exhaustion (i.e. task failure). To avoid any
protective pacing strategy, average power during the first two
sprints was controlled to reach at least 95% of the best average of
the two isolated sprints, which was the case in all subjects. Subjects
were never given any indication on the number of sprints
performed. A minimal PF of 70 rpm after 5 s or less of sprinting
was set as a criterion to stop subjects’ test. However, volitional
exhaustion was observed in all subjects before this criterion was
reached. Unfinished sprints (subjects not being able to turn pedals
anymore) where not taken into consideration.
3 min All-Out Test
45 min after the RSA test, subjects performed a 3-min all-out
test following a protocol well described elsewhere [26] in order to
determine 3-min average power output. Strong verbal encour-
agement was given throughout the test and PF was instructed to be
as high as possible all time to elicit maximal all-out performance.
Information about elapsed time was only given during the final
minute every 15 seconds in order to prevent pacing and further
motivate subjects. A peak in oxygen consumption (VO2peak) was
calculated as the highest 30 s average value during the test with
a gas exchange analyzer (Metalyzer, Cortex Medical, Leipzig,
Germany). Although residual fatigue from the RSA test was
probable, this test was performed for all subjects at the same
moment of the testing sequence allowing for a good comparison of
subjects’ aerobic capacity (average power during 3 min). For this
test, the ergometer was set in linear mode (power output increases
as PF increases).
30 s Wingate Test
Prior to the first and last training sessions, subjects performed
a standard 30 s Wingate test [27] after a 6 min warm-up at 120 W
and the average power during the 30 s was recorded.
Statistical Analyses
Data are presented as mean (SD). Performance and blood
perfusion changes during RSA test were first evaluated with a 2-
way (training group6sprint number) general linear model re-
peated-measures ANOVA with all pairwise multiple comparison
procedures (Holm-Sidak method). Performance improvement,
muscle oxygenation during RSA, mRNA concentrations, blood
lactate and other single variables test were then evaluated with 2-
way (training group6time (Pre- vs. Post-)) general linear model
repeated-measures ANOVAs with all pairwise multiple compar-
ison procedures (Holm-Sidak method). All analyses were made
using Sigmaplot 11.0 software (Systat Software, CA, USA). Null
hypothesis was rejected at p,0.05.
Results
Total work and training intensity during supervised RS training
were similar during RSN and RSH, with only the mean heart rate
being higher in RSH (Table 2). In addition to specific training in
the laboratory, subjects trained similarly for 5.062.5 h and
5.162.2 h for the RSH and RSN groups, respectively.
Performance
From Pre- to Post-, the average power of all sprints during the
RSA test increased (p,0.01) to the same extent (667% vs. 768%,
NS) in RSH and in RSN, respectively, but not in CON (265%,
NS). The number of sprints prior to exhaustion was increased in
RSH (9.464.8 vs. 13.066.2, p,0.01) but not in RSN (9.364.2 vs.
8.963.5, NS) nor in CON (11.067.1 vs. 10.366.2, NS). In Post-
compared to Pre-, 10-s average power in the successive sprints was
significantly improved till the ninth sprint in RSH and till the
seventh in RSN. In RSH, this 10-s power output was significantly
better (p,0.01) in the 10th and 11th sprints in Post- than the ninth
sprint in Pre- (Fig. 3). Significant group (RSH vs. RSN) by time
(Pre- vs. Post-) interactions were found in the number of sprints
(F = 24.22; p,0.001) and total work (F= 27.07; p,0.001)
performed during the RSA test. Subjects reached volitional
exhaustion at the same relative power output (e.g. % of the best
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Figure 2. Typical signals recorded by near-infrared spectroscopy during repeated sprint ability test after signal treatment,
maximum and minimum determination and smoothing. Concentrations of O2Hb, HHb and tHb are expressed as changes in mM from resting
baseline set to 0 mM.
doi:10.1371/journal.pone.0056522.g002
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sprint) in RSH (67611% vs. 6968% for Pre- vs. Post-,
respectively, NS) and in RSN (6567% vs. 6869%, NS). From
Pre- to Post-, average PF during the last 5 s of all successive sprints
was improved to the same extent (p,0.01) in RSH (96614 vs.
104611) and in RSN (100611 vs. 110610) but not in CON
(10362 vs. 10363, NS). The maximal PF of each sprint was
higher (p,0.01) in Post- both in RSH (124611 vs. 13068) and in
RSN (12568 vs. 13168) but not in CON (12963 vs. 13064, NS).
The average power during the 3-min all-out test as well as
hematocrit and hemoglobin concentration at rest were unchanged
between Pre- and Post- in all groups (Tables 3 and 4). RSH and
RSN improved single 10-s sprint and Wingate performances
(p,0.01) similarly whereas it did not change in CON (Table 4).
Muscle Oxygenation
Repeated sprints. After training, D[tHb]av increased to
a greater extent (F= 15.8, p,0.01) in RSH than in RSN and
was not different in Pre- and in Post- in CON (Fig. 4B).
Meanwhile, D[HHb]av increased similarly in RSH (from
7966% to 9865%, p,0.01) and in RSN (from 10663% to
120610%, p,0.01) but was not different in Pre- and in Post- in
CON (11869% vs. 121613%, NS).
The average D[tHb]/Power ratio increased to a greater extent
(F = 9.1, p,0.05) in RSH (from 1.6460.25 to 2.2360.35, p,0.01)
than in RSN (from 1.6860.15 to 1.9860.30, p,0.05) and was not
different Pre- compared to Post- in CON (1.6160.26 vs.
1.5660.33, NS).
Recovery phases. After training, D[tHb]av increased to
a similar extent in RSH and in RSN but was not different Pre-
compared to Post- in CON (Fig. 5B).
Meanwhile, D[HHb]av increased significantly only in RSH
(from 9867 to 115612%, p,0.05) but not in RSN (105612% vs.
116610%, NS) nor in CON (10968% vs. 113613%, NS).
Elextromyographic Activity
From Pre- to Post-, average RMS activity of the VL muscle was
not different in RSH (0.5360.23 vs. 0.5060.16 mV, NS), in RSN
(0.4960.15 vs. 0.5160.12 mV, NS) or in CON (0.5360.21 vs.
0.5160.19 mV). Similarly, from Pre- to Post-, average RMS
activity of the BF muscle was not different in RSH (0.2260.09 vs.
0.2460.10 mV, NS), in RSN (0.2060.08 vs. 0.2260.09 mV, NS)
or in CON (0.2260.05 vs. 0.2460.18 mV, NS). RMS activity of
the VL across the RSA test decreased relatively to the first sprint
(set to 100%) but to a similar extent in RSH (9168% vs. 8969%,
NS), RSN (86611% vs. 87612%, NS) or in CON (89610% vs.
8866%, NS) in Pre- vs. Post-, respectively.
mRNA Selected Gene Transcripts and Enzyme Activity
Figure 6 displays Pre- and Post- mRNA expression levels in
RSH, RSN and CON groups. In Post- compared to Pre-, mRNA
gene concentrations of hypoxia inducible factor (HIF-1a, +55%,
p,0.05), carbonic anhydrase III (CA3, +35%, p,0.05), mono-
carboxylate transporter-4 (MCT-4, +20%, p,0.05) and lactate
dehydrogenase (LDH, +12%, p,0.05) were augmented in RSH
only. Conversely, mitochondrial transcription factor A (TFAM),
peroxisome proliferator-activated receptor gamma coactivator 1a
(PGC-1a) and monocarboxylate transporter-1 (236%, p,0.01)
concentrations were decreased in RSH only (240% and 223%
respectively, p,0.01) (Fig. 6). From Pre- to Post-, LDH activity
was increased in RSH (63.6613.8 vs. 71.3614.2, p,0.05) but not
in RSN (56.3614.8 vs. 61.7616.2, NS). Citrate synthase activity
was not different and did not vary significantly in RSH (8.662.5
vs. 10.662.7, NS) and in RSN (8.563.1 vs. 8.563.8).
Discussion
The principal novel finding of this investigation is that repeated
sprint training in hypoxia allows further enhancement of repeated-
sprint performance to exhaustion than the same training in
normoxia. Second, in RSH, the amplitude of blood flow variations
during sprint phases was increased. Third, the increased mRNA
expression of factors involved in pH regulation and glycolysis as
well as the decrease in factors involved in mitochondrial biogenesis
after RSH suggest a potential enhancement of the glycolytic (but
not oxidative) activity in muscle.
Repeated Sprint Ability and Cycling Performance
Improvement
RSH and RSN elicited similar significant power improvements
(,6–7%) but hypoxic training only additionally delayed the
decrease of power output and therefore extended the number of
sprints performed. The ability to reach a higher PF and maintain it
high during the last 5 s of the successive sprints explains the power
improvements both in RSH and RSN. Indeed, maximal power
production (e.g. during repeated sprints) is related to the ability to
recruit more FT at very high PF [28] and FT are known to be
essential in the power production when intensity increases [29].
Consequently, the observed increase in power can be attributed to
an improved muscle recruitment strategy (e.g. additional FT
motor units [30]) and inter-muscle coordination [22]. Noteworthy,
like RSH, RSN improved average and maximal power output of
the sprints; so the specific training performed is useful compared to
CON in improving power during repeated sprints.
In addition, the aerobic performance (3-min all-out) was not
modified after training (Table 4). Similarly, improvement of single
10-s sprint and Wingate performance did not differ between RSH
and RSN. This was expected since intermittent training in hypoxia
is known to be rather inefficient for additional performance
improvements in endurance athletes, when compared to similar
training performed in normoxia [6].
Blood Flow Variations and Delayed Exhaustion during
RSA Test
D[tHb] represents changes in blood volume in the muscle (i.e.
blood perfusion) [31] so it is expected to vary widely during the
RSA test. Since PF was higher in Post- and D[tHb] is influenced
by cycle frequency [32], the increase in D[tHb]av was expected
and could contribute to higher power production both in RSH
and RSN. Then, during the repeated sprint test, fatigue appeared
rapidly, highlighted by the power decrement (,33–35%, Fig. 3)
throughout the set. At the muscular level, waste metabolites
Table 2. Total work and measured parameters during all
training sessions in the hypoxic (RSH) and normoxic (RSN)
training groups.
RSH RSN
Total work (kJ) 27286242 27386335
Mean peak power output (W) 9606117 10036146
Mean heart rate (bpm) 151612 141612#
Mean RPE 16.261.4 16.761.5
« Pain in the legs » VAS 7.061.9 7.660.9
RPE, Rate of perceived exertion (Borg 6–20 scale); VAS, Visual analogic 1–10
scale.
#p,0.05 for difference with RSH.
doi:10.1371/journal.pone.0056522.t002
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accumulation and energy supply are certainly essential limiting
factors in RSA performance [33]. During RS phosphocreatine
breakdown is very high [12] and inorganic phosphate (Pi)
accumulates in muscle. Since increased Pi levels may decline
force, especially in FT recruited during such fatiguing exercise
[34], an improved waste metabolites removal when blood flow is
raised [35] might delay fatigue during a RSA test. This is in
accordance with the greater increase in D[tHb]av during sprints in
Figure 3. Average power output (W) in successive sprints during the repeated sprint test before (Pre-) and after (Post-) the specific
repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in control group (CON).
doi:10.1371/journal.pone.0056522.g003
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RSH compared to RSN and the increase of the D[tHb] to power
ratio, so it can be argued that blood perfusion was improved in
RSH and could explain additional sprints performed in RSH.
Moreover, during sprinting, due to the high PF, FT are
predominantly recruited [28,36]. FT are mainly glycolytic [37]
and contribute highly to the energy supply during RS [33]. More
sprints in RSH could then be explained by an improved behavior
of FT although it requires to optimize the contribution of
anaerobic glycolysis known to be impaired as sprints are repeated
[33]. Indeed, due to the poorer O2 delivery to working FT
(compared to slow twitch (ST)) and their greater fractional O2
extraction if highly perfused [16], these fibers are likely to benefit
more from the higher blood perfusion during sprints in RSH. This
could help enhancing microvascular O2 delivery to FT, minimiz-
ing substrate level phosphorylation and intracellular perturbation
(e.g. Pi accumulation and decreased pH), thereby ‘‘making FT to
behave more like their oxidatively efficient ST counterparts’’ [38].
Then, with more FT recruited and working with less anaerobic
energy dependence, fiber fatigue could potentially be diminished
[39].
Interestingly, a recent study underlined a higher decrease in
power output but with similar [tHb] kinetics during a RSA test
performed in hypoxia compared to normoxia [40]. However,
during our supervised training, RS power output did not decrease
more in RSH than in RSN (since total work was similar (Table 3)).
This could be explained by the training including only sets of 5
repeated sprints and therefore limiting power decrements. Then
the improved [tHb] kinetics (i.e. D[tHb]) we observed might have
been elicited by the greater exercise:rest ratio used (1:2) inducing
shortened recoveries.
When exercising, the O2 availability to demand ratio is lowered
and muscle tissue oxygen delivery is maintained by an increased
extraction of O2 in blood [41]. A more severe reduction of the
ratio (e.g. during repeated sprints) requires an adapted arterial flow
control (e.g. vasodilatation) to ensure adequate tissue perfusion
[10]. In addition, during exercise in hypoxia the compensatory
vasodilatation (with an increase in blood perfusion) aims at
maintaining constant the total O2 delivery to the muscle [10].
Alongside, in hypoxia there is an increased sympathetic vasocon-
strictor activity directed towards skeletal muscle [42] that occurs to
a greater extent within FT (glycolytic type II fibers in rat) [43].
However, ‘‘the compensatory vasodilatation prevails over the
vasoconstrictor response’’ and exercise intensity is essential in the
amplitude of this compensatory vasodilatation [10]. So, maximal
Table 3. Subjects’ characteristics before (Pre-) and after (Post-
) repeated sprint training in hypoxia (RSH), in normoxia (RSN)
or in the control group (CON).
RSN RSH CON
Pre- Post- Pre- Post- Pre- Post-
Body mass (kg) 73.767.7 73.768.1 76.8610.476.5610.1 76.4611.0 75.8611.3
Hematocrit (%) 45.662.7 45.462.2 44.262.7 44.862.4 44.962.6 45.762.7
Hemoglobin
(g.l21)
152612 154612 153612 154616 15468 15769
VO2peak
(l.min21)
3.860.5 4.060.4 3.860.4 3.860.4 3.960.5 3.960.5
VO2peak, peak in oxygen consumption measured during 3-min all-out test.
doi:10.1371/journal.pone.0056522.t003
Table 4. Performance results before (Pre-) and after (Post-) repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in the
control group (CON).
RSH RSN CON
Pre- Post- Pre- Post- Pre- Post-
Single 10-s sprint average power (W)8706132 9256120** 8796131 9406131** 8906151 8776163
RSA Peak Power (W) 13656311 15006217** 13516226 14276275* 13576275 13776322
RSA Peak heart rate (bpm) 173614 175611 17268 17268 171610 171611
RSA Best average power (W) 8706133 9256120** 8796131 9406131** 8706151 8776163
RSA Mean power of all
sprints (W)
699697 737684** 6936120 7346104** 7266115 7476125
RSA [La] (mmol.l-1) 15.062.3 15.462.1 14.261.7 14.861.6 14.862.0 13.861.5
RSA Average RPE 17.361.5 17.461.7 17.861.4 17.861.5 17.861.0 17.660.8
RSA Average « Pain in the
legs » VAS
5.262 6.761.9** 5.861.9 7.761.7** 6.462.3 6.161.8
30 s Wingate average
power (W)
6996102 718694** 688675 723686** 670686 6896105
30 s Wingate [La] (mmol.l21) 11.062.2 12.062.0 11.362.3 11.062.2 10.863.0 11.462.5
30 s Wingate Average RPE 15.362.0 16.161.9 16.361.6 17.061.6 15.861.7 16.060.9
3-min all-out average
power (W)
368645 383639 371649 382647 385648 378648
3-min all-out [La] (mmol.l21) 14.762.1 15.061.9 14.562.0 15.162.0 14.262.6 13.862.4
3-min all-out RPE 17.561.7 18.061.7 18.161.8 18.761.1 17.861.0 17.961.0
RSA, repeated sprint ability test; [La] Blood lactate concentration after repeated sprint test; RPE, rate of perceived exertion (Borg 6–20 scale); VAS, visual analogic scale
(1–10) score.
**p,0.01,
*p,0.05 for difference with Pre-.
doi:10.1371/journal.pone.0056522.t004
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Figure 4. D[tHb]: successive changes in total hemoglobin concentrations’ amplitude during sprints (expressed in percent compared
to the first sprint) measured by near infrared-spectroscopy (A) and D[tHb]av: average of all changes during the repeated sprint test
to exhaustion (B) before (Pre-) and after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in
control group (CON).
doi:10.1371/journal.pone.0056522.g004
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Figure 5. D[tHb]: successive changes in total hemoglobin concentrations’ amplitude during recovery phases between sprints
(expressed in percent compared to the first recovery phase) measured by near infrared-spectroscopy (A) and D[tHb]av: average of
all changes during the repeated sprint test to exhaustion (B) before (Pre-) and after (Post-) the specific repeated sprint training in
hypoxia (RSH), in normoxia (RSN) or in control group (CON).
doi:10.1371/journal.pone.0056522.g005
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Figure 6. Relative mRNA expression of selected gene transcripts after 4 weeks of specific repeated sprint training before (Pre-) and
after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in control group (CON). Open bars represent
Pre- values and solid bars Post- values of mRNA concentrations in vastus lateralis muscle. Post- values were expressed in % compared to Pre- values
(set to 100%). HIF-1a, hypoxia inducible factor-1a; VEGF, vascular endothelial growth factor; MB, myoglobin; PGC1-a, proliferator-activated receptor
gamma coactivator-1a; TFAM, mitochondrial transcription factor A; CA3, carbonic anhydrase III; MCT-1, monocarboxylate transporter-1; MCT-4,
monocarboxylate transporter-4; LDH, lactate dehydrogenase.
doi:10.1371/journal.pone.0056522.g006
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exercise intensities (e.g. in sprints) may maximize this amplitude.
Though muscle fatigue attenuates the vasodilatory responsiveness
[44] and the delayed fatigue during RSA test in RSH could then
partly be due to an improved responsiveness of the vascular bed.
Interestingly, blood flow and vascular conductance were shown to
be augmented mostly in FT after dietary nitrate supplementation
[43]. In accordance with the increase in D[tHb]av in RSH (Fig. 4B),
one may finally hypothesize that RSH enhancing predominantly
FT behavior could participate to the improved blood perfusion
through nitric oxide mediated vasodilatation mechanisms [10].
However, it must be admitted that data collected by NIRS might
only represent muscle perfusion indirectly and should be
interpreted with care. In addition, we did not observe significant
differences in thigh muscle electromyography between groups.
Nevertheless voluntary activation was reported not to differ during
short-term hypoxia even at a higher altitude [45].
Still, the proposed mechanism based on the preferential
recruitment and modified behavior of FT with an enhanced
vasodilatory compensation induced in RSH is appealing as it could
also explain why previous IHT studies [6–8] with lower exercise
intensities failed to demonstrate additional benefits to endurance
performance when compared to similar normoxic training. In
these latter studies, FT fibers recruitment might not have been
high enough since intensity was 2–4 fold lower than with the
present RS training.
Molecular Adaptations after Specific Training
Besides, performance and blood perfusion results are in
accordance with the expression levels of some mRNAs. Our
protocol including only brief periods of hypoxic training was
sufficient for inducing a significant upregulation of HIF-1a. Such
elevation in HIF-1a mRNA leads to a downstream activation of
HIF-1 dependent pathway [46]. The subsequent increase in
mRNA expression of CA3 and improved activity of LDH
additionally suggests an increased capacity for pH regulation
[47], although no significant difference in blood lactate was
observed between Pre- and Post-. Indeed we also observed
a decrease in mRNA expression of genes implicated in mitochon-
drial biogenesis such TFAM and PGC-1a while LDH concentra-
tion was increased. Moreover, citrate synthase activity was not
different between RSH and RSN suggesting that oxidative
capacity was not different. Our study therefore indicates a shift
from aerobic to anaerobic glycolytic activity in the muscle not in
line with the previously suggested enhanced oxidative capacity
after IHT [4,5,48]. In addition, we observed an upregulation of
MCT-4 and a downregulation of MCT-1 in RSH. MCT-4 is
mostly expressed in glycolytic tissues (i.e. FT) where it mediates
lactic acid efflux [49] from the cells whereas MCT-1 is adapted to
supply lactate to the cells for energy production [50]. Again, as
MCT-4 (but not MCT-1) is upregulated by hypoxia [49], our
results are in line with the hypothesis that more sprints performed
during RSA were due mainly to modified FT fibers behavior.
Although this study confirms an elevated HIF1-a mRNA expres-
sion after exercising at high-intensity during short exposures in
hypoxia (and not in normoxia), the observed changes are largely
different than the previously reported HIF-1 mediated muscle
adaptations after IHT [5,48] but underlines specific adaptations in
RSH. Yet we also confirm the key role of exercise intensity per se
during hypoxic training [9]. Overall, the upregulation of genes
involved in oxygen signaling (HIF-1a), oxygen carrying (Mb) and
pH regulation (CA3) and the concomitant downregulation of
genes implicated in mitochondrial biogenesis (TFAM and PGC-
1a) suggest a shift from aerobic to anaerobic glycolytic activity in
the muscle.
Conclusions
This study is the first to observe larger performance improve-
ment after repeated sprint training in hypoxia than for to the same
training in normoxia. Our main novel findings were that repeated
sprint training in hypoxia leads to i) increased variations of blood
perfusion possibly delaying fatigue during a RSA test and ii)
specific molecular adaptations large enough for inducing further
improvement in systemic RSA performance. Our results suggest
an improved vascular conductance in repeated sprints to
exhaustion where fast-twitch fibers are likely better utilized.
Fatigue could potentially be delayed through FT working with
less anaerobic energy dependence. In parallel to the increased
blood perfusion and potentially better waste metabolites removal,
modifications at the molecular level support a shift towards
improved anaerobic glycolytic activity following RS training in
hypoxia only.
In conclusion, this study reports the effectiveness of RSH for
improving intermittent exercises performed in normoxia. The
mechanisms are likely largely different than those previously
associated to the inefficient IHT.
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